Altimmune News and Activities

Altimmune is one of the...

• Russell 3000;
• TOB Iconic 10,000.

Altimmune is a company listed under the stock ticker ALT (US).

View the org chart displaying its 22 main executives

Most searched biographies at Altimmune

• Vipin Garg, Director, President and Chief Executive Officer
• John Gill, Director
• Mitchel Sayare, Executive Chairman of the Board

Popular executive movements at Altimmune

• Teri Lawver has joined the company as Director  (posted on February 26 2025).
• Greg Weaver has joined the company as Chief Financial Officer  (posted on November 12 2024).

Create your alert
to follow the executive moves at Altimmune.

Altimmune has 1,826 competitors including Pfizer (United States (USA)), Sanofi (France) and Johnson & Johnson (United States (USA)).

Popular M&A news in Pharmaceuticals

• Danone has announced the acquisition of Kate Farms  (posted on May 14 2025).
• Cyclo Therapeutics has acquired Rafael Holdings (posted on April 28 2025).
• Chimerix and Chimerix have merged  (posted on April 22 2025)..

Popular contacts in Pharmaceuticals

• Estelle Vester-Blokland - Senior Vice President, Medical and Head, International Markets at Bristol-Myers Squibb
• Seth Harrison - Chairman and Director at Braeburn Pharmaceuticals
• Fred Davenport - Lead Director at Medpace

Learn more about the Pharmaceuticals industry

Press releases by Altimmune

• Altimmune Presents New Analyses Predicting High Rates of MASH Resolution on Biopsy following Pemvidutide Treatment at the EASL International Liver Congress™ – Altimmune
• Altimmune to Report First Quarter 2025 Financial Results and Provide Business Update on May 13, 2025 – Altimmune
• Altimmune to Participate in the Citizens Life Sciences Conference – Altimmune
• Altimmune to Present at Upcoming EASL International Liver Congress™ 2025 – Altimmune
• Altimmune to Host Virtual R&D Day on March 13, 2025 – Altimmune
• Altimmune Announces Fourth Quarter and Full Year 2024 Financial Results and Provides a Business Update – Altimmune
• Altimmune to Participate in the Leerink Global Healthcare Conference – Altimmune
• Seasoned Biopharmaceutical Industry Executives Teri Lawver and Jerry Durso Appointed to Altimmune Board of Directors – Altimmune
• Altimmune to Report Fourth Quarter and Full Year 2024 Financial Results and Provide Business Update on February 27, 2025 – Altimmune
• Altimmune to Participate in the Guggenheim SMID Cap Biotech Conference – Altimmune
• View more press releases Close

Social media about Altimmune

• Altimmune on Wikipedia, Google News & Yahoo Finance
• Altimmune on LinkedIn, Twitter & YouTube